CD4 response up to 5 years after combination antiretroviral therapy in human immunodeficiency virus-infected patients in Latin America and the Caribbean
Author
dc.contributor.author
Luz, Paula M.
Author
dc.contributor.author
Belaunzarán Zamudio, Pablo
Author
dc.contributor.author
Crabtree Ramírez, Brenda
Author
dc.contributor.author
Caro Vega, Yanink
Author
dc.contributor.author
Hoces, Daniel
Author
dc.contributor.author
Rebeiro, Peter F.
Author
dc.contributor.author
Blevins, Meridith
Author
dc.contributor.author
Pape, Jean W.
Author
dc.contributor.author
Cortés Moncada, Claudia
Author
dc.contributor.author
Padgett, Denis
Author
dc.contributor.author
Cahn, Pedro
Author
dc.contributor.author
Veloso, Valdilea G.
Author
dc.contributor.author
McGowan, Catherine C.
Author
dc.contributor.author
Grinsztejn, Beatriz
Author
dc.contributor.author
Shepherd, Bryan E.
Admission date
dc.date.accessioned
2019-03-18T11:54:26Z
Available date
dc.date.available
2019-03-18T11:54:26Z
Publication date
dc.date.issued
2015
Cita de ítem
dc.identifier.citation
Open Forum Infectious Diseases, Volumen 2, Issue 2, 2018,
Identifier
dc.identifier.issn
23288957
Identifier
dc.identifier.other
10.1093/ofid/ofv079
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/166830
Abstract
dc.description.abstract
We describe CD4 counts at 6-month intervals for 5 years after combination antiretroviral therapy initiation among 12 879 antiretroviral-naive human immunodeficiency virusinfected adults from Latin America and the Caribbean. Median CD4 counts increased from 154 cells/mm3 at baseline (interquartile range [IQR], 60-251) to 413 cells/mm3 (IQR, 234-598) by year 5.
CD4 response up to 5 years after combination antiretroviral therapy in human immunodeficiency virus-infected patients in Latin America and the Caribbean